Delivery Order SPE2DB22D1106-SPE2DB25FERH0
Award Date 6/2/25
Potential Completion Date 6/3/25
Potential Value $6.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $1,709.46 delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Dupixent 300 mg/2 ml syringes (2 ml quantity). This firm fixed-price contract, with a completion date of July 16, 2025, represents a non-set-aside competitive award delivered to the company's Conshohocken, Pennsylvania location. Dupixent is a biologic medication used primarily for treating moderate-to-severe atopic dermatitis and other inflammatory...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,860.78 for Dupixent 300 mg/2 ml syringes on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which is not set-aside, will be performed at the company's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and other inflammatory conditions, making...
- The Defense Logistics Agency awarded a $69,305.82 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes on May 27, 2025, with completion scheduled for May 28, 2025. This firm fixed price contract represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly prescribed for severe asthma, eczema, and other inflammatory conditions, making this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $8,010.37 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Dupixent 300 mg/2 ml syringes with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory...
- The Defense Logistics Agency awarded a $10,256.76 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory conditions, and this award reflects the Department of Defense's ongoing pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $47,569.78 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on November 14, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by November 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and is issued as a child order under...
- The Defense Logistics Agency awarded a $7,694.26 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of November 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,464.61 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat...
- The Defense Logistics Agency awarded a delivery order valued at $17,795.66 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory conditions, and...
- The Defense Logistics Agency awarded a $31,152.11 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes with a completion date of August 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...